The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Different behavior of branched and linear polyethylenimine for gene deliveryin vitro andin vivo
Abstract
BACKGROUND: Efficient gene transfer is a major challenge for non-viral gene therapy. Understanding how non-viral vectors initiate gene expression could lead to the development of new future vectors with enhanced efficacy. METHODS: Linear or branched polyethylenimine (PEI)/DNA complexes were generated in varying salt conditions and their transfection efficiencies were compared in vitro and in vivo using reporter genes, luciferase and green fluorescent protein, and rhodamine labeled DNA (pGeneGrip). RESULTS: The transfection efficiency of linear PEI22/DNA in vitro was generally greater than that of branched PEI/DNA when complexes were generated in salt containing buffer. However, PEI complexes generated under salt-free conditions generally had low transfection activity in vitro. In contrast, PEI22/DNA salt-free complexes were highly active in vivo. Branched PEI/DNA and salt containing PEI22/DNA complexes were generally 10-100-fold less active than the salt-free PEI22/DNA complexes. Salt-free PEI22/DNA complexes were small, but subsequently grew into aggregates when salt was added. In contrast, PEI25/DNA complexes remained small even after salt was added under the same conditions. Furthermore, PEI22/pGeneGrips complexes formed large aggregates associated with the cell membrane, cytoplasm and nucleus, while branched PEI complexes remained as small distinct particles associated with the cell membrane or in the cytoplasm. CONCLUSIONS: Branched and linear PEI/DNA complexes differ in their ability to transfect cells. The greater efficiency of linear PEI might be due to an inherent kinetic instability under salt conditions. Understanding how to employ this kinetic instability of linear PEI could help in designing future vectors with greater flexibility and transfection efficiency in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
Ogris, M., Brunner, S., Schüller, S., Kircheis, R., & Wagner, E. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300900 · Cited by 1,178
Self-citationTracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery
Godbey, W. T., Wu, K. K., & Mikos, A. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5177 · Cited by 822
Tang, M., & Szoka, F. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300454 · Cited by 814
Plank, C., Mechtler, K., Szoka, F. C., & Wagner, E. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.12-1437 · Cited by 583
Self-citationOgris, M., Steinlein, P., Kursa, M., Mechtler, K., Kircheis, R., & Wagner, E. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300745 · Cited by 571
Self-citationAbdallah, B., Hassan, A., Benoist, C., Goula, D., Behr, J. P., & Demeneix, B. A. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.16-1947 · Cited by 541
Polylysine-based transfection systems utilizing receptor-mediated delivery
Zauner, W., Ogris, M., & Wagner, E. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00110-5 · Cited by 504
Self-citationNonviral Gene Therapy: The Promise of Genes as Pharmaceutical Products
Ledley, F. D. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.9-1129 · Cited by 468
Nomenclature for Synthetic Gene Delivery Systems
(1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.5-511 · Cited by 448
Cited by
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Nonviral vectors for gene delivery
Mintzer, M. A., & Simanek, E. E. (2009) · Chemical Reviews · doi:10.1021/cr800409e · Cited by 2,366
Nanostructured materials for applications in drug delivery and tissue engineering
Goldberg, M., Langer, R., & Jia, X. (2007) · Journal of Biomaterials Science, Polymer Edition · doi:10.1163/156856207779996931 · Cited by 1,054
Polyethylenimine-based non-viral gene delivery systems
Lungwitz, U., Breunig, M., Blunk, T., & Göpferich, A. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.11.011 · Cited by 983
Gene Therapy Progress and Prospects: Nonviral vectors
Niidome, T., & Huang, L. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301923 · Cited by 963
Current status of polymeric gene delivery systems☆
PARK, T., JEONG, J., & KIM, S. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.03.007 · Cited by 944
Neu, M., Fischer, D., & Kissel, T. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.773 · Cited by 866
Viral and nonviral delivery systems for gene delivery
Nayerossadat, N., Maedeh, T., & Ali, P. (2012) · Advanced Biomedical Research · doi:10.4103/2277-9175.98152 · Cited by 858
Rejman, J., Bragonzi, A., & Conese, M. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.03.038 · Cited by 851
Kunath, K. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00076-2 · Cited by 809
Prospects for cationic polymers in gene and oligonucleotide therapy against cancer
Merdan, T., Kopec̆ek, J., & Kissel, T. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00046-7 · Cited by 785
Progress in developing cationic vectors for non-viral systemic gene therapy against cancer
Morille, M., Passirani, C., Vonarbourg, A., Clavreul, A., & Benoit, J.-P. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.04.036 · Cited by 769
Mendes, B. B., Conniot, J., Avital, A., Yao, D., Jiang, X., Zhou, X., Sharf-Pauker, N., Xiao, Y., Adir, O., Liang, H., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00104-y · Cited by 719
Nonviral Gene Delivery: Principle, Limitations, and Recent Progress
Al-Dosari, M. S., & Gao, X. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9143-y · Cited by 706
An overview of current delivery systems in cancer gene therapy
El-Aneed, A. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.09.013 · Cited by 693
Design and gene delivery activity of modified polyethylenimines
Kircheis, R., Wightman, L., & Wagner, E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00202-2 · Cited by 651
Self-citationGene delivery by lipoplexes and polyplexes
Tros de Ilarduya, C., Sun, Y., & Düzgüneş, N. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.03.019 · Cited by 627
Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond)
Lächelt, U., & Wagner, E. (2015) · Chemical Reviews · doi:10.1021/cr5006793 · Cited by 600
Self-citationA combinatorial polymer library approach yields insight into nonviral gene delivery
Green, J. J., Langer, R., & Anderson, D. G. (2008) · Accounts of Chemical Research · doi:10.1021/ar7002336 · Cited by 579
Advances in biomedical applications of pectin gels
Munarin, F., Tanzi, M. C., & Petrini, P. (2012) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2012.07.002 · Cited by 576
Wang, H.-X., Li, M., Lee, C. M., Chakraborty, S., Kim, H.-W., Bao, G., & Leong, K. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00799 · Cited by 560
Self‐Assembly of Hyperbranched Polymers and Its Biomedical Applications
Zhou, Y., Huang, W., Liu, J., Zhu, X., & Yan, D. (2010) · Advanced Materials · doi:10.1002/adma.201000369 · Cited by 560
Nanomedicine in pulmonary delivery
Mansour, H., Haemosu, & Wu, X. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s4937 · Cited by 485
Simple Modifications of Branched PEI Lead to Highly Efficient siRNA Carriers with Low Toxicity
Zintchenko, A., Philipp, A., Dehshahri, A., & Wagner, E. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800065f · Cited by 467
Self-citationPurification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer
Boeckle, S., von Gersdorff, K., van der Piepen, S., Culmsee, C., Wagner, E., & Ogris, M. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.598 · Cited by 447
Self-citationBreaking up the correlation between efficacy and toxicity for nonviral gene delivery
Breunig, M., Lungwitz, U., Liebl, R., & Goepferich, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703882104 · Cited by 443
Nonviral gene delivery: What we know and what is next
Gao, X., Kim, K.-S., & Liu, D. (2007) · The AAPS Journal · doi:10.1208/aapsj0901009 · Cited by 431
Polymer systems for gene delivery—Past, present, and future
Wong, S. Y., Pelet, J. M., & Putnam, D. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.007 · Cited by 427
Non-viral gene delivery systems
Davis, M. E. (2002) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(02)00294-x · Cited by 419
Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium
Patel, A. K., Kaczmarek, J. C., Bose, S., Kauffman, K. J., Mir, F., Heartlein, M. W., DeRosa, F., Langer, R., & Anderson, D. G. (2019) · Advanced Materials · doi:10.1002/adma.201805116 · Cited by 381
Polymeric Delivery of Therapeutic Nucleic Acids
Kumar, R., Santa Chalarca, C. F., Bockman, M. R., Bruggen, C. V., Grimme, C. J., Dalal, R. J., Hanson, M. G., Hexum, J. K., & Reineke, T. M. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00997 · Cited by 365
DNA Nanoparticles and Development of DNA Delivery Vehicles for Gene Therapy
Vijayanathan, V., Thomas, T., & Thomas, T. J. (2002) · Biochemistry · doi:10.1021/bi0203987 · Cited by 360
Therapeutic plasmid DNA versus siRNA delivery: Common and different tasks for synthetic carriers
Scholz, C., & Wagner, E. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.014 · Cited by 333
Self-citationvon Gersdorff, K., Sanders, N. N., Vandenbroucke, R., De Smedt, S. C., Wagner, E., & Ogris, M. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.07.006 · Cited by 314
Self-citationLipid-Based DNA Therapeutics: Hallmarks of Non-Viral Gene Delivery
Buck, J., Grossen, P., Cullis, P. R., Huwyler, J., & Witzigmann, D. (2019) · ACS Nano · doi:10.1021/acsnano.8b07858 · Cited by 312
Kursa, M., Walker, G. F., Roessler, V., Ogris, M., Roedl, W., Kircheis, R., & Wagner, E. (2003) · Bioconjugate Chemistry · doi:10.1021/bc0256087 · Cited by 310
Self-citationPolymers for siRNA Delivery: Inspired by Viruses to be Targeted, Dynamic, and Precise
Wagner, E. (2012) · Accounts of Chemical Research · doi:10.1021/ar2002232 · Cited by 308
Self-citationHu, Y., Litwin, T., Nagaraja, A. R., Kwong, B., Katz, J., Watson, N., & Irvine, D. J. (2007) · Nano Letters · doi:10.1021/nl071542i · Cited by 305
In Vitro and in Vivo mRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles
Su, X., Fricke, J., Kavanagh, D. G., & Irvine, D. J. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100390w · Cited by 287
Generation of magnetic nonviral gene transfer agents and magnetofection in vitro
Mykhaylyk, O., Antequera, Y. S., Vlaskou, D., & Plank, C. (2007) · Nature Protocols · doi:10.1038/nprot.2007.352 · Cited by 272
Cancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery
Vaughan, H. J., Green, J. J., & Tzeng, S. Y. (2020) · Advanced Materials · doi:10.1002/adma.201901081 · Cited by 255
Large-Scale transfection of mammalian cells for the fast production of recombinant protein
Pham, P. L., Kamen, A., & Durocher, Y. (2006) · Molecular Biotechnology · doi:10.1385/mb:34:2:225 · Cited by 236
Challenges in CRISPR/CAS9 delivery: potential roles of nonviral vectors
Li, L., He, Z.-Y., Wei, X.-W., Gao, G.-P., & Wei, Y.-Q. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.069 · Cited by 202
Metadata
- Authors
- Wightman, L., Kircheis, R., R�ssler, V., Carotta, S., Ruzicka, R., Kursa, M., & Wagner, E.
- Venue
- The Journal of Gene Medicine
- Publisher
- Wiley
- Published
- 2001
- Volume
- 3
- Issue
- 4
- Pages
- 362-372
- ISSN
- 1099-498X (ISSN-L)
- 1521-2254
- OpenAlex
- W2002151233
- Cited by
- 697
- References
- 26
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.